Hsin‐Yuan Cheng

453 total citations
15 papers, 345 citations indexed

About

Hsin‐Yuan Cheng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Hsin‐Yuan Cheng has authored 15 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Immunology. Recurrent topics in Hsin‐Yuan Cheng's work include CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Immune Cell Function and Interaction (4 papers). Hsin‐Yuan Cheng is often cited by papers focused on CAR-T cell therapy research (8 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Immune Cell Function and Interaction (4 papers). Hsin‐Yuan Cheng collaborates with scholars based in United States, Taiwan and United Kingdom. Hsin‐Yuan Cheng's co-authors include Runpei Wu, Catherine C. Hedrick, Cesar Sommer, Barbra J. Sasu, Duy Nguyen, Chantel McSkimming, Coleen A. McNamara, Dalia E. Gaddis, Mary G. Sorci‐Thomas and Janette Sutton and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Hsin‐Yuan Cheng

15 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hsin‐Yuan Cheng United States	9	158	155	138	51	48	15	345
Xuelian Hu China	12	196 1.2×	182 1.2×	144 1.0×	63 1.2×	14 0.3×	16	423
Olga Klimenkova Germany	7	150 0.9×	153 1.0×	92 0.7×	92 1.8×	14 0.3×	14	388
Fédérica De Paoli France	8	227 1.4×	141 0.9×	120 0.9×	25 0.5×	51 1.1×	15	420
Koby Kidder United States	10	266 1.7×	88 0.6×	86 0.6×	22 0.4×	32 0.7×	12	374
Denise Sickert Switzerland	9	163 1.0×	103 0.7×	69 0.5×	25 0.5×	51 1.1×	14	363
Patricia Quade-Lyssy Germany	7	76 0.5×	145 0.9×	125 0.9×	65 1.3×	18 0.4×	9	335
Silvia Panetti United Kingdom	5	252 1.6×	131 0.8×	210 1.5×	54 1.1×	15 0.3×	6	425
Xiaoxuan Fan United States	9	142 0.9×	184 1.2×	77 0.6×	13 0.3×	26 0.5×	32	337
Christina Paluskievicz United States	9	231 1.5×	122 0.8×	174 1.3×	22 0.4×	45 0.9×	11	421
Amy Blatchley United States	7	450 2.8×	161 1.0×	107 0.8×	16 0.3×	24 0.5×	7	549

Countries citing papers authored by Hsin‐Yuan Cheng

Since Specialization

Citations

This map shows the geographic impact of Hsin‐Yuan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin‐Yuan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin‐Yuan Cheng more than expected).

Fields of papers citing papers by Hsin‐Yuan Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin‐Yuan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin‐Yuan Cheng. The network helps show where Hsin‐Yuan Cheng may publish in the future.

Co-authorship network of co-authors of Hsin‐Yuan Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin‐Yuan Cheng. A scholar is included among the top collaborators of Hsin‐Yuan Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin‐Yuan Cheng. Hsin‐Yuan Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lin, Regina, Janette Sutton, Trevor Bentley, et al.. (2023). Constitutive Turbodomains enhance expansion and antitumor activity of allogeneic BCMA CAR T cells in preclinical models. Science Advances. 9(31). eadg8694–eadg8694. 3 indexed citations

Sasu, Barbra J., Elvin J. Lauron, Thomas F. Schulz, Hsin‐Yuan Cheng, & Cesar Sommer. (2023). Allogeneic CAR T Cell Therapy for Cancer. 8(1). 227–243. 7 indexed citations

Hansen, Kyle, Sandeep Kumar, Kathryn Logronio, et al.. (2021). COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade. Cancer Immunology Immunotherapy. 70(12). 3525–3540. 29 indexed citations

Sommer, Cesar, Hsin‐Yuan Cheng, Duy Nguyen, et al.. (2020). Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery. Molecular Therapy. 28(10). 2237–2251. 70 indexed citations

Sommer, Cesar, Regina Lin, Janette Sutton, et al.. (2020). Preclinical Evaluation of ALLO-605, an Allogeneic BCMA Turbocar TTM Cell Therapy for the Treatment of Multiple Myeloma. Blood. 136(Supplement 1). 8–8. 8 indexed citations

Tân, Nguyêñ Duy, Hsin‐Yuan Cheng, Yi Zhang, et al.. (2020). Investigation of ALLO-316: A Fratricide-Resistant Allogeneic CAR T Targeting CD70 As a Potential Therapy for the Treatment of AML. Blood. 136(Supplement 1). 23–23. 8 indexed citations

Sommer, Cesar, Hsin‐Yuan Cheng, Yik A. Yeung, et al.. (2019). Preclinical Evaluation of ALLO-819, an Allogeneic CAR T Cell Therapy Targeting FLT3 for the Treatment of Acute Myeloid Leukemia. Blood. 134(Supplement_1). 3921–3921. 2 indexed citations

Panowski, Siler H., Thomas Van Blarcom, Cesar Sommer, et al.. (2019). Investigation of Allocar TTM Targeting CD70 As a Potential Therapy for an Array of Hematological Malignancies. Blood. 134(Supplement_1). 5157–5157. 1 indexed citations

Cheng, Hsin‐Yuan, Dalia E. Gaddis, Runpei Wu, et al.. (2016). Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. Journal of Clinical Investigation. 126(9). 3236–3246. 66 indexed citations

10.

Cheng, Hsin‐Yuan, Runpei Wu, & Catherine C. Hedrick. (2014). Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis. Atherosclerosis. 234(2). 265–269. 25 indexed citations

11.

Cheng, Hsin‐Yuan, Runpei Wu, Abraham K. Gebre, et al.. (2013). Increased Cholesterol Content in Gammadelta (γδ) T Lymphocytes Differentially Regulates Their Activation. PLoS ONE. 8(5). e63746–e63746. 37 indexed citations

12.

Pamuklar, Zehra, Jin Sun Lee, Hsin‐Yuan Cheng, et al.. (2008). Individual Heterogeneity in Platelet Response to Lysophosphatidic Acid. Arteriosclerosis Thrombosis and Vascular Biology. 28(3). 555–561. 38 indexed citations

13.

Cheng, Hsin‐Yuan, Yuyu Lin, Chunying Yu, et al.. (2005). Molecular Identification of Canine Podocalyxin-Like Protein 1 as a Renal Tubulogenic Regulator. Journal of the American Society of Nephrology. 16(6). 1612–1622. 22 indexed citations

14.

Cheng, Hsin‐Yuan, et al.. (2004). Doxycycline‐ and tetracycline‐regulated transcriptional silencer enhance the expression level and transactivating performance of rtTA. The Journal of Gene Medicine. 6(12). 1403–1413. 7 indexed citations

15.

Lai, Jen-Feng, Shin‐Hun Juang, Hsin‐Yuan Cheng, et al.. (2003). An ecdysone and tetracycline dual regulatory expression system for studies on Rac1 small GTPase-mediated signaling. American Journal of Physiology-Cell Physiology. 285(3). C711–C719. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact